New-onset Atrial Fibrillation Among COVID-19 Patients: A Narrative Review

Overview

Journal World J Crit Care Med

Publisher Baishideng Publishing Group

Specialty Critical Care

Date 2024 Jan 8

PMID 38188450

Authors

Fahimeh Talaei

Akshat Banga

Amanda Pursell

Ann Gage

Namratha Pallipamu

Amith Reddy Seri

Ramesh Adhikari

Rahul Kashyap

Salim Surani

Affiliations

Soon will be listed here.

Abstract

Over the last three years, research has focused on examining cardiac issues arising from coronavirus disease 2019 (COVID-19) infection, including the emergence of new-onset atrial fibrillation (NOAF). Still, no clinical study was conducted on the persistence of this arrhythmia after COVID-19 recovery. Our objective was to compose a narrative review that investigates COVID-19-associated NOAF, emphasizing the evolving pathophysiological mechanisms akin to those suggested for sustaining AF. Given the distinct strategies involved in the persistence of atrial AF and the crucial burden of persistent AF, we aim to underscore the importance of extended follow-up for COVID-19-associated NOAF. A comprehensive search was conducted for articles published between December 2019 and February 11, 2023, focusing on similarities in the pathophysiology of NOAF after COVID-19 and those persisting AF. Also, the latest data on incidence, morbidity-mortality, and management of NOAF in COVID-19 were investigated. Considerable overlaps between the mechanisms of emerging NOAF after COVID-19 infection and persistent AF were observed, mostly involving reactive oxygen pathways. With potential atrial remodeling associated with NOAF in COVID-19 patients, this group of patients might benefit from long-term follow-up and different management. Future cohort studies could help determine long-term outcomes of NOAF after COVID-19.

Citing Articles

Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis.

Iqbal K, Banga A, Arif T, Rathore S, Bhurwal A, Naqvi S World J Methodol. 2024; 14(3):92983.

PMID: 39310244 PMC: 11230074. DOI: 10.5662/wjm.v14.i3.92983.

The role of atrial fibrillation in vascular cognitive impairment and dementia: epidemiology, pathophysiology, and preventive strategies.

Fekete M, Liotta E, Molnar T, Fulop G, Lehoczki A Geroscience. 2024; 47(1):287-300.

PMID: 39138793 PMC: 11872872. DOI: 10.1007/s11357-024-01290-1.

Complications of new-onset atrial fibrillation in critically ill COVID-19 patients admitted to the intensive care unit (ICU): a meta-analysis.

Zhang T, Gui P, Wang B BMC Cardiovasc Disord. 2024; 24(1):407.

PMID: 39103764 PMC: 11299389. DOI: 10.1186/s12872-024-04086-5.

Permanent and Persistent Atrial Fibrillations Are Independent Risk Factors of Mortality after Severe COVID-19.

Zajac A, Wrona E, Kasprzak J J Clin Med. 2024; 13(11).

PMID: 38892823 PMC: 11172445. DOI: 10.3390/jcm13113112.

COVID-19 pandemic and trends in clinical outcomes and medication use for patients with established atrial fibrillation: A nationwide analysis of claims data.

Hernandez I, Yang L, Tang S, Cameron T, Guo J, Gabriel N Am Heart J Plus. 2024; 42:100396.

PMID: 38689680 PMC: 11059438. DOI: 10.1016/j.ahjo.2024.100396.

References

Linz D, Elliott A, Hohl M, Malik V, Schotten U, Dobrev D . Role of autonomic nervous system in atrial fibrillation. Int J Cardiol. 2018; 287:181-188. DOI: 10.1016/j.ijcard.2018.11.091. View

Denham N, Pearman C, Caldwell J, Madders G, Eisner D, Trafford A . Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure. Front Physiol. 2018; 9:1380. PMC: 6180171. DOI: 10.3389/fphys.2018.01380. View

McEwan P, Gray G, Sherry L, Webb D, Kenyon C . Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation. 1998; 98(24):2765-73. DOI: 10.1161/01.cir.98.24.2765. View

Kardalas E, Paschou S, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A . Hypokalemia: a clinical update. Endocr Connect. 2018; 7(4):R135-R146. PMC: 5881435. DOI: 10.1530/EC-18-0109. View

Bansal M . Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020; 14(3):247-250. PMC: 7102662. DOI: 10.1016/j.dsx.2020.03.013. View

Alfano G, Ferrari A, Fontana F, Perrone R, Mori G, Ascione E . Hypokalemia in Patients with COVID-19. Clin Exp Nephrol. 2021; 25(4):401-409. PMC: 7781399. DOI: 10.1007/s10157-020-01996-4. View

Singh R, Kashyap R, Hutton A, Sharma M, Surani S . A Review of Cardiac Complications in Coronavirus Disease 2019. Cureus. 2020; 12(5):e8034. PMC: 7282366. DOI: 10.7759/cureus.8034. View

Miyasaka Y, Barnes M, Bailey K, Cha S, Gersh B, Seward J . Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007; 49(9):986-92. DOI: 10.1016/j.jacc.2006.10.062. View

Scialo F, Daniele A, Amato F, Pastore L, Matera M, Cazzola M . ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung. 2020; 198(6):867-877. PMC: 7653219. DOI: 10.1007/s00408-020-00408-4. View

10.

Corradi D . Atrial fibrillation from the pathologist's perspective. Cardiovasc Pathol. 2014; 23(2):71-84. DOI: 10.1016/j.carpath.2013.12.001. View

11.

Gopinathannair R, Merchant F, Lakkireddy D, Etheridge S, Feigofsky S, Han J . COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020; 59(2):329-336. PMC: 7268965. DOI: 10.1007/s10840-020-00789-9. View

12.

Chen L, Li X, Chen M, Feng Y, Xiong C . The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020; 116(6):1097-1100. PMC: 7184507. DOI: 10.1093/cvr/cvaa078. View

13.

Xu X, Lai Y, Hua Z . Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2018; 39(1). PMC: 6340950. DOI: 10.1042/BSR20180992. View

14.

Colston J, Boylston W, Feldman M, Jenkinson C, de la Rosa S, Barton A . Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Biochem Biophys Res Commun. 2007; 354(2):552-8. PMC: 1847636. DOI: 10.1016/j.bbrc.2007.01.030. View

15.

Francis Stuart S, De Jesus N, Lindsey M, Ripplinger C . The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J Mol Cell Cardiol. 2016; 91:114-22. PMC: 4764395. DOI: 10.1016/j.yjmcc.2015.12.024. View

16.

Hu W, Xie J, Zhu T, Meng G, Wang M, Zhou Z . Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement. Cardiol Res Pract. 2020; 2020:1358098. PMC: 7174944. DOI: 10.1155/2020/1358098. View

17.

Mujovic N, Dobrev D, Marinkovic M, Russo V, Potpara T . The role of amiodarone in contemporary management of complex cardiac arrhythmias. Pharmacol Res. 2019; 151:104521. DOI: 10.1016/j.phrs.2019.104521. View

18.

Mattson M, Chan S . Calcium orchestrates apoptosis. Nat Cell Biol. 2003; 5(12):1041-3. DOI: 10.1038/ncb1203-1041. View

19.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L . Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5):531-538. PMC: 7087935. DOI: 10.1007/s00392-020-01626-9. View

20.

Chen Q, Xu L, Dai Y, Ling Y, Mao J, Qian J . Cardiovascular manifestations in severe and critical patients with COVID-19. Clin Cardiol. 2020; 43(7):796-802. PMC: 7323347. DOI: 10.1002/clc.23384. View